Patent ID: 11857630
Assignee: TYNDALL FORMULATION SERVICES, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 21:
22. The method according to claim 20, wherein the cancer is selected from one or more of colorectal, non-small cell lung carcinoma, small cell lung carcinoma, adenocarcinoma of the pancreas, ovarian, gastric, esophageal, breast cancer, multiple myeloma, breast, ovary, cervix, prostate, testis, genitourinary tract, esophagus, larynx, glioblastoma, neuroblastoma, gastric, skin, keratoacanthoma, lung, epidermoid carcinoma, large cell carcinoma, small cell carcinoma, small cell lung carcinoma, non-small cell lung carcinoma, lung, bone, colon, thyroid, adenoma, pancreas, adenocarcinoma, adenocarcinoma of pancreas, thyroid, follicular carcinoma, undifferentiated carcinoma, papillary carcinoma, seminoma, melanoma, uveal melanoma, sarcoma, bladder carcinoma, liver carcinoma (e.g., hepatocellular carcinoma (HCC)) and biliary passages, kidney carcinoma, myeloid disorders, lymphoid disorders, Hodgkin's disease, hairy cells, tumors of mesenchymal origin including fibrosarcoma and rhabdomyosarcoma, buccal cavity and pharynx, lip, tongue, mouth, pharynx, small intestine, colorectal carcinoma, large intestine, rectum, brain and central nervous system, endometrial, multiple myeloma, prostate, acute myeloid leukemia and leukemia.